trastuzumab deruxtecan
roche,astrazeneca,daiichi sankyo
['t-dxd', 'genentech']
lewis what s next?
antibody drug conjugates adcs
1 t-dm1
2 t-dxd bi-specific antibodies- engage another immune receptor #aacr23 
Cancer Research Patient Advocate at UNC Lineberger CCC. Breast & Liver cancer, clinical trials, PROMs, #SciComm Featured Voice FCOI: https://t.co/PzlQKUfjUw